Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
08/05/2014 | CA2649269C Protein complex and process for producing the same |
08/05/2014 | CA2608315C Use of a new gene coding for a new member of the mcm2-8 family in pharmaceutical compositions |
08/05/2014 | CA2607344C Wheat having new starch and method for producing it |
08/05/2014 | CA2607150C Glucagon-like-peptide-2 (glp-2) analogues |
08/05/2014 | CA2581840C Optimized vaccines to provide protection against ebola and other viruses |
08/05/2014 | CA2557737C Insulin-like growth factor (igf-i) plasmid-mediated supplementation for therapeutic applications |
08/05/2014 | CA2555390C Immunostimulatory viral rna oligonucleotides |
08/05/2014 | CA2553886C Combined use of prame inhibitors and hdac inhibitors |
08/05/2014 | CA2552892C O-linked glycosylation of peptides |
08/05/2014 | CA2507115C Treatment of mammalian reaction to ige interactions |
08/05/2014 | CA2505316C Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
08/05/2014 | CA2501554C Regulation of type ii collagen gene expression using specific and selective electrical and electromagnetic signals |
08/05/2014 | CA2466431C Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
08/05/2014 | CA2465325C Antibodies for inhibiting blood coagulation and methods of use thereof |
08/05/2014 | CA2461351C Mutated anti-cd22 antibodies with increased affinity to cd22-expressing leukemia cells |
08/05/2014 | CA2457140C Beta-amyloid-analogue - t-cell epitope vaccine |
08/05/2014 | CA2390670C Method of determining susceptibility to bipolar disorders |
07/31/2014 | WO2014117185A1 Rift valley fever virus glycoproteins, gn and gc, and their use |
07/31/2014 | WO2014116989A1 Maize event dp-032218-9 and methods for detection thereof |
07/31/2014 | WO2014116958A1 Compositions and methods involving endogenous retrovirus proteins |
07/31/2014 | WO2014116854A1 Maize event dp-033121-3 and methods for detection thereof |
07/31/2014 | WO2014116721A1 Geminiviral vector for expression of rituximab |
07/31/2014 | WO2014116704A1 Phosphoribosyl pyrophosphate synthetase 2 (prps2) as a therapeutic target in cancer treatment |
07/31/2014 | WO2014116042A1 Recombinant strain for producing 2,3-butanediol, comprising (a) inactivated lactate dehydrogenase and (b) inactivated sucrose regulator |
07/31/2014 | WO2014115158A1 METHOD FOR INHIBITING TUMOR GROWTH THROUGH RNA-INTERFERENCE USING LIPOSOMALLY ASSOCIATED CDC20 siRNA |
07/31/2014 | WO2014115123A1 Plants having enhanced yield-related traits and method for making the same |
07/31/2014 | WO2014115104A1 Influenza virus reassortment |
07/31/2014 | WO2014115103A1 Composition comprising an encapsulated antagomir |
07/31/2014 | WO2014115087A2 A method for the preparation of recombinant human prothrombin and fibrinogen |
07/31/2014 | WO2014115039A2 Method and apparatus for detecting leaks in a pipeline network |
07/31/2014 | WO2014115022A1 A helper-dependent adenoviral gene therapy delivery and expression system |
07/31/2014 | WO2014114934A1 Methods for improving the efficiency of gene targeting |
07/31/2014 | WO2014113846A1 Herbicide tolerant barley |
07/31/2014 | WO2014093655A3 Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains |
07/31/2014 | WO2014089533A3 Algal mutants having a locked-in high light acclimated phenotype |
07/31/2014 | WO2014071266A3 Alteration of sex determination in flowering plants |
07/31/2014 | WO2013138044A8 Methods and materials for noninvasive detection of colorectal neoplasia associated with inflammatory bowel disease |
07/31/2014 | WO2013046216A8 Two plasmid mammalian expression system |
07/31/2014 | US20140215657 Quantitative Trait Loci Associated With Soybean Cyst Nematode Resistance And Methods Of Their Use |
07/31/2014 | US20140215656 Methods and Compositions for Plant Pest Control |
07/31/2014 | US20140215655 Guard cell-specific expression of transgenes in cotton |
07/31/2014 | US20140215653 Identification and use of early embryo and/or early endosperm specific promoters for gene expression in maize |
07/31/2014 | US20140215652 Nucleotide sequences mediating male fertility and method of using same |
07/31/2014 | US20140215651 Kentucky bluegrass variety named 'barvette' selected for healthy turf |
07/31/2014 | US20140215650 Plants and seeds of sorghum variety gsv548207 |
07/31/2014 | US20140215649 Plants and seeds of sorghum variety gsv672338 |
07/31/2014 | US20140215648 Plants and seeds of sorghum variety gsv415986 |
07/31/2014 | US20140215646 Cotton transgenic event mon 88701 and methods of use thereof |
07/31/2014 | US20140215645 Tomato hybrid foronti and parents thereof |
07/31/2014 | US20140213826 Recombinant Synthesis of Medium Chain-Length Alkanes |
07/31/2014 | US20140213780 Process for separation of oligonucleotide of interest from a mixture |
07/31/2014 | US20140213779 Riboswitches |
07/31/2014 | US20140213770 High-throughput antibody humanization |
07/31/2014 | US20140213640 Virus-like particles for treatment of viral infections |
07/31/2014 | US20140213639 Optimization of Vectors for Effective Delivery and Expression of Genetic Content |
07/31/2014 | US20140213637 Agents for Improved Delivery of Nucleic Acids to Eukaryotic Cells |
07/31/2014 | US20140213636 Method of treating hyperproliferation of cells using a nucleolin specific aptamer |
07/31/2014 | US20140213635 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure |
07/31/2014 | US20140213634 Method for proliferation cardiomyocytes using micro-rna |
07/31/2014 | US20140213633 Method for proliferation cardiomyocytes using micro-rna |
07/31/2014 | US20140213631 Methods for modulating kallikrein (klkb1) expression |
07/31/2014 | US20140213630 Methods and pharmaceutical compositions for treating lymphoid malignancy |
07/31/2014 | US20140213629 Molecular targets for healing or treating wounds |
07/31/2014 | US20140213628 Compositions and methods for the treatment of sepsis and other disorders involving phospholipase a2 induction |
07/31/2014 | US20140213530 Methods for treatment of cancer by targeting sirt5 |
07/31/2014 | US20140213510 Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
07/31/2014 | US20140213485 Methods For Preparing cDNA From Low Quantities of Cells |
07/31/2014 | US20140213482 Simple method for detcting pluripotent stem cells genetically modified by homologous recombination |
07/31/2014 | US20140213462 Strategies for high throughput identification and detection of polymorphisms |
07/31/2014 | US20140213460 RNA-YY1 Interactions |
07/31/2014 | US20140213459 Antibodies with improved folding stability |
07/31/2014 | US20140212977 Methods For Producing Multiple Recombinant Polypeptides In A Filamentous Fungal Host Cell |
07/31/2014 | US20140212976 Recombinant microorganisms comprising NADPH dependent enzymes and methods of production therefor |
07/31/2014 | US20140212969 Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis |
07/31/2014 | US20140212953 Yeast microorganisms with reduced by-product accumulation for improved production of fuels, chemicals, and amino acids |
07/31/2014 | US20140212951 Expression conditions and methods of human recombinant growth and differentiaton factor-5 (rhgdf-5) |
07/31/2014 | US20140212939 Cytochrome p450s and uses thereof |
07/31/2014 | US20140212934 Biological synthesis of difunctional hexanes and pentanes from carbohydrate feedstocks |
07/31/2014 | US20140212922 Two plasmid mammalian expression system |
07/31/2014 | US20140212897 Methods for predicting pregnancy outcome in a subject by hcg assay |
07/31/2014 | US20140212886 Shuttle vectors for corynebacterium and escherichia coli |
07/31/2014 | US20140212871 Nucleic Acid Extraction from Heterogeneous Biological Materials |
07/31/2014 | US20140212868 Method and Kit For The Isolation Of Genomic DNA, RNA Proteins and Metabolites From A Single Biological Sample |
07/31/2014 | US20140212446 Novel Artificial Antigen Presenting Cells and Uses Thereof |
07/31/2014 | US20140212438 Nuclear targeting sequences |
07/31/2014 | US20140212437 Methods and compositions for treating atrial fibrillation |
07/31/2014 | US20140212434 Multivalent vaccines for rabies virus and filoviruses |
07/31/2014 | US20140212412 Use of il-33 antagonists to treat fibrotic disease |
07/31/2014 | US20140212411 Methods of treatment using anti-erbb antibody-maytansinoid conjugates |
07/31/2014 | US20140212407 Treatment of obesity |
07/31/2014 | US20140212395 DOWNREGULATION OF miR-7 FOR PROMOTION OF BETA CELL DIFFERENTIATION AND INSULIN PRODUCTION |
07/31/2014 | US20140212394 Novel vip3 toxins and methods of use |
07/30/2014 | EP2759596A1 Short interfering ribonucleic acid (siRNA) |
07/30/2014 | EP2759595A1 Composition comprising an encapsulated antagomir |
07/30/2014 | EP2759594A1 Novel 2-deoxy-scyllo-inosose synthase |
07/30/2014 | EP2759593A1 Novel ADAMTS-13 mutant |
07/30/2014 | EP2758778A1 Screening method |
07/30/2014 | EP2758775A2 Novel use of leucyl trna synthetase |
07/30/2014 | EP2758537A1 Monomer architecture of tal nuclease or zinc finger nuclease for dna modification |
07/30/2014 | EP2758536A1 Human keratinocytes ptch1 cell line |